XML 56 R44.htm IDEA: XBRL DOCUMENT v3.21.2
SCHEDULE OF SHARE-BASED COMPENSATION, STOCK OPTIONS AND STOCK APPRECIATION RIGHTS AWARD ACTIVITY (Details) - Stock Appreciation Rights (SARs) [Member] - USD ($)
$ / shares in Units, $ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2021
Jun. 30, 2020
Jun. 30, 2021
Jun. 30, 2020
Dec. 31, 2020
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]          
Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Outstanding, Number 1,729,879   1,729,879   2,161,556
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price $ 63.76   $ 63.76   $ 60.48
Granted (in shares) 3,398 0 139,592 262,091  
Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price     $ 77.05    
Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Exercised     (558,550)    
Weighted Average Exercise Price, Exercises in Period (in dollars per share)     $ 54.65    
Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Forfeitures     (12,719)    
Weighted Average Exercise Price, Forfeitures in Period (in dollars per share)     $ 52.57    
Weighted Average Remaining Contractual Term, Outstanding (in years)     5 years 10 months 24 days    
Aggregate Intrinsic Value, Outstanding $ 69,154   $ 69,154    
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Number 1,359,501   1,359,501    
Weighted Average Exercise Price, Exercisable (in dollars per share) $ 64.73   $ 64.73    
Weighted Average Remaining Contractual Term, Exercisable (in years)     5 years 1 month 6 days    
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value $ 53,041   $ 53,041    
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value     $ 24,900